Literature DB >> 9819797

Inversion of chromosome 16 in accelerated phase of chronic myeloid leukaemia: report of a case and review of the literature.

M Colović1, G Janković, J Bila, V Djordjević, P H Wiernik.   

Abstract

A patient with a Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) developed a blast crisis (FAB subtype AML-M2) without a monocytic involvement. Karyotype showed the presence of inv(16)(p13;q22) in addition to Ph, in 16/20 marrow metaphases.

Entities:  

Mesh：

Year:  1998        PMID： 9819797     DOI： 10.1007/bf02821939

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


  9 in total

1.  Inversion of chromosome 16 and dysplastic eosinophils in accelerated phase of chronic myeloid leukemia.

Authors:  H Enright; D Weisdorf; L Peterson; R E Rydell; M E Kaplan; D C Arthur
Journal:  Leukemia       Date:  1992-05       Impact factor: 11.528

2.  Inversion of chromosome 16 with the Philadelphia chromosome in acute myelomonocytic leukemia with eosinophilia. Report of two cases.

Authors:  L M Secker-Walker; G J Morgan; T Min; G J Swansbury; J Craig; T Yamada; L Desalvo; J W Medina; V Chowdhury; R P Donahue
Journal:  Cancer Genet Cytogenet       Date:  1992-01

3.  Early transformation to acute myeloblastic leukaemia with the acquisition of inv(16) in Ph positive chronic granulocytic leukaemia.

Authors:  H Myint; F M Ross; J L Hall; T J Hamblin
Journal:  Leuk Res       Date:  1997-05       Impact factor: 3.156

4.  Acute myelomonocytic leukemia with inv(16)(p13q22) complicating Philadelphia chromosome positive chronic myeloid leukemia.

Authors:  S Heim; B E Christensen; T Fioretos; A G Sørensen; N T Pedersen
Journal:  Cancer Genet Cytogenet       Date:  1992-03

5.  Inversion of chromosome 16 and bone marrow eosinophilia in a myelomonocytic transformation of chronic myeloid leukemia.

Authors:  N Asou; I Sanada; K Tanaka; M Hidaka; H Suzushima; H Matsuzaki; F Kawano; K Takatsuki
Journal:  Cancer Genet Cytogenet       Date:  1992-07-15

Review 6.  The biological significance of the multidrug resistance gene MRP in inversion 16 leukemias.

Authors:  B J Kuss; R G Deeley; S P Cole; C L Willman; K J Kopecky; S R Wolman; H J Eyre; D F Callen
Journal:  Leuk Lymphoma       Date:  1996-02

7.  Detection of CBFB/MYH11 transcripts in patients with inversion and other abnormalities of chromosome 16 at presentation and remission.

Authors:  K Tobal; P R Johnson; M J Saunders; C J Harrison; J A Liu Yin
Journal:  Br J Haematol       Date:  1995-09       Impact factor: 6.998

8.  Temporal association of marrow eosinophilia with inversion of chromosome 16 in recurrent blast crises of chronic myelogenous leukemia.

Authors:  J P Evers; A Bagg; E Himoe; J A Zwiebel; R J Jacobson
Journal:  Cancer Genet Cytogenet       Date:  1992-09

9.  Heterogeneity in CBF beta/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia.

Authors:  S A Shurtleff; S Meyers; S W Hiebert; S C Raimondi; D R Head; C L Willman; S Wolman; M L Slovak; A J Carroll; F Behm
Journal:  Blood       Date:  1995-06-15       Impact factor: 22.113
  9 in total
  2 in total

1.  Myeloid neoplasms with concurrent BCR-ABL1 and CBFB rearrangements: A series of 10 cases of a clinically aggressive neoplasm.

Authors:  Alireza Salem; Sanam Loghavi; Guilin Tang; Yang O Huh; Elias J Jabbour; Hagop Kantarjian; Wei Wang; Shimin Hu; Rajyalakshmi Luthra; L Jeffrey Medeiros; Joseph D Khoury
Journal:  Am J Hematol       Date:  2017-04-06       Impact factor: 10.047

2.  Coexistence of p210BCR-ABL and CBFβ-MYH11 fusion genes in myeloid leukemia: A report of 4 cases.

Authors:  Yuan-Yuan Wang; Wen-Jing Ding; Feng Jiang; Zi-Xing Chen; Jian-Nong Cen; Xiao-Fei Qi; Jian-Ying Liang; Dan-Dan Liu; Jin-Lan Pan; Su-Ning Chen
Journal:  Oncol Lett       Date:  2017-08-24       Impact factor: 2.967
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.